| 1 | gpfgesundheit project foundation early | | | | | | | 1 | 0.22% |
| 2 | new drug candidates which | | | | | | | 1 | 0.22% |
| 3 | effective treatments in cancer | | | | | | | 1 | 0.22% |
| 4 | become effective treatments in | | | | | | | 1 | 0.22% |
| 5 | could become effective treatments | | | | | | | 1 | 0.22% |
| 6 | that could become effective | | | | | | | 1 | 0.22% |
| 7 | agents that could become | | | | | | | 1 | 0.22% |
| 8 | anticancer agents that could | | | | | | | 1 | 0.22% |
| 9 | candidates which researchers found | | | | | | | 1 | 0.22% |
| 10 | drug candidates which researchers | | | | | | | 1 | 0.22% |
| 11 | 20 new drug candidates | | | | | | | 1 | 0.22% |
| 12 | breakthroughs include the development | | | | | | | 1 | 0.22% |
| 13 | of 20 new drug | | | | | | | 1 | 0.22% |
| 14 | identification of 20 new | | | | | | | 1 | 0.22% |
| 15 | of these included the | | | | | | | 1 | 0.22% |
| 16 | some of these included | | | | | | | 1 | 0.22% |
| 17 | cancer some of these | | | | | | | 1 | 0.22% |
| 18 | of cancer some of | | | | | | | 1 | 0.22% |
| 19 | symptoms of cancer some | | | | | | | 1 | 0.22% |
| 20 | and symptoms of cancer | | | | | | | 1 | 0.22% |
| 21 | causes and symptoms of | | | | | | | 1 | 0.22% |
| 22 | other breakthroughs include the | | | | | | | 1 | 0.22% |
| 23 | include the development of | | | | | | | 1 | 0.22% |
| 24 | with new information about | | | | | | | 1 | 0.22% |
| 25 | effective drugs to the | | | | | | | 1 | 0.22% |
| 26 | foundation does not limit | | | | | | | 1 | 0.22% |
| 27 | the foundation does not | | | | | | | 1 | 0.22% |
| 28 | types the foundation does | | | | | | | 1 | 0.22% |
| 29 | treatments for patients cancer | | | | | | | 1 | 0.22% |
| 30 | cancer treatments for patients | | | | | | | 1 | 0.22% |
| 31 | improving cancer treatments for | | | | | | | 1 | 0.22% |
| 32 | and improving cancer treatments | | | | | | | 1 | 0.22% |
| 33 | market and improving cancer | | | | | | | 1 | 0.22% |
| 34 | healthcare market and improving | | | | | | | 1 | 0.22% |
| 35 | and effective drugs to | | | | | | | 1 | 0.22% |
| 36 | the development of 15 | | | | | | | 1 | 0.22% |
| 37 | new and effective drugs | | | | | | | 1 | 0.22% |
| 38 | bringing new and effective | | | | | | | 1 | 0.22% |
| 39 | to bringing new and | | | | | | | 1 | 0.22% |
| 40 | critical to bringing new | | | | | | | 1 | 0.22% |